STUDY finds that #COVID19 vaccine effectiveness (VE) was 78% and increased to 89% after boosting during the Delta-dominant study period, but VE of primary vaccination was significantly reduced in those aged 60+ and patients with malignancy, chronic cardiac disease or an immunocompromising condition.
Add comment